...
首页> 外文期刊>Business week >A Stimulant for Depressed Drug Stocks?
【24h】

A Stimulant for Depressed Drug Stocks?

机译:抑郁症药物库存的刺激物?

获取原文
获取原文并翻译 | 示例
           

摘要

For a bunch of can't-miss stocks, the big drugmakers sure did miss out on 2003's bull run. The dozen drug companies in the Standard & Poor's 500-stock index have returned 10% this year, vs. the index' 22%. You know why: failed drug trials, political blowback at high prices, generic rivals. Not long ago, Wall Street saw Big Pharma shares as a perfect portfolio complement to the fistfuls of (legal) pills being popped by baby boomers in their fogeyhood. Instead, they proved stone downers.
机译:对于一大堆不容错过的股票,大型制药商肯定错过了2003年的牛市。标准普尔500指数中的十二家制药公司今年的回报率为10%,而该指数的回报率为22%。你知道为什么:药物试验失败,高价政治反弹,仿制药竞争对手。不久前,华尔街将Big Pharma的股票视为完美的投资组合,以补充婴儿潮一代在迷雾笼罩中涌现出的(合法)药片。相反,他们证明了石棺。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号